MDxHealth reported Q2 2024 revenue of $42.0M, beat analyst consensus of $21.2M by $20.8M. Diluted EPS came in at $-0.31, missed the $-0.26 consensus by $0.05.
Filings will appear here once submitted to SEC EDGAR.
Common questions about MDxHealth's Q2 2024 earnings report.
MDxHealth (MDXH) reported Q2 2024 earnings on August 21, 2024 after market close.
MDxHealth reported revenue of $42.0M and diluted EPS of $-0.31 for Q2 2024.
Revenue beat the consensus estimate of $21.2M by $20.8M. EPS missed the consensus estimate of $-0.26 by $0.05.